In a Phase 3 trial of more than 18,000 volunteers across three countries, an mRNA influenza vaccine from Pfizer has outperformed standard seasonal flu shots by 34.5%. It's yet another sign that this ...

A new mRNA vaccine against the flu has proven itself more effective than existing vaccines in a new clinical trial. The Pfizer-developed vaccine was found to be 34.5 percent more effective than ...

The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical trial stages, the first COVID-19 mRNA vaccine was administered on 8 December ...

A new study has found that receiving messenger RNA-based COVID-19 vaccines such as those from Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) could boost the survival rates of ...

Advisers to RFK Jr drop the plan to end federal guidance amid Republican worries about the political impact ...

Covid vaccines may come with a tantalizing benefit that has nothing to do with the virus they’re designed to protect against: boosting the immune system to better fight tumors during cancer treatment.

Researchers at MIT have just developed a new lipid nanoparticle that super-enhances the effectiveness of the mRNA vaccine in mice to a hundred times its stand-alone effectiveness, thus offering ...

A key U.S. federal vaccine advisory ​panel has dropped a push against COVID mRNA ‌vaccines, the Washington Post reported on Wednesday, citing two people familiar with the matter.